IL142249A0 - Method of treating thrombocytopenic purpura and hemolytic uremic syndrome - Google Patents

Method of treating thrombocytopenic purpura and hemolytic uremic syndrome

Info

Publication number
IL142249A0
IL142249A0 IL14224999A IL14224999A IL142249A0 IL 142249 A0 IL142249 A0 IL 142249A0 IL 14224999 A IL14224999 A IL 14224999A IL 14224999 A IL14224999 A IL 14224999A IL 142249 A0 IL142249 A0 IL 142249A0
Authority
IL
Israel
Prior art keywords
thrombocytopenic purpura
uremic syndrome
hemolytic uremic
provides
treating thrombocytopenic
Prior art date
Application number
IL14224999A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL142249A0 publication Critical patent/IL142249A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Enzymes And Modification Thereof (AREA)
IL14224999A 1998-12-10 1999-12-01 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome IL142249A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11177098P 1998-12-10 1998-12-10
PCT/US1999/028433 WO2000033867A1 (en) 1998-12-10 1999-12-01 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome

Publications (1)

Publication Number Publication Date
IL142249A0 true IL142249A0 (en) 2002-03-10

Family

ID=22340356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14224999A IL142249A0 (en) 1998-12-10 1999-12-01 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome

Country Status (13)

Country Link
US (2) US20010003740A1 (de)
EP (1) EP1137432B1 (de)
JP (1) JP2002531519A (de)
CN (1) CN1329503A (de)
AT (1) ATE264113T1 (de)
AU (1) AU1838500A (de)
BR (1) BR9915984A (de)
CA (1) CA2351555A1 (de)
DE (1) DE69916493T2 (de)
ES (1) ES2219094T3 (de)
IL (1) IL142249A0 (de)
WO (1) WO2000033867A1 (de)
ZA (1) ZA200102730B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002028416A1 (ja) * 2000-09-30 2004-02-12 持田製薬株式会社 溶血性貧血の予防・治療剤
US20100284997A1 (en) * 2006-10-31 2010-11-11 Griffin John H Dosing regimen of activated protein c and variants having reduced anticoagulant activity
CN111035754A (zh) * 2016-03-23 2020-04-21 兆科药业（合肥）有限公司 抗血小板溶栓素在制备治疗血栓性血小板减少性紫癜的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
ZA983496B (en) * 1997-04-28 1999-10-25 Lilly Co Eli Methods for processing activated protein C.

Also Published As

Publication number Publication date
EP1137432B1 (de) 2004-04-14
ZA200102730B (en) 2002-07-03
DE69916493T2 (de) 2005-03-24
CA2351555A1 (en) 2000-06-15
US20010003740A1 (en) 2001-06-14
ES2219094T3 (es) 2004-11-16
ATE264113T1 (de) 2004-04-15
CN1329503A (zh) 2002-01-02
DE69916493D1 (de) 2004-05-19
US20040087643A1 (en) 2004-05-06
BR9915984A (pt) 2001-09-04
JP2002531519A (ja) 2002-09-24
WO2000033867A1 (en) 2000-06-15
AU1838500A (en) 2000-06-26
EP1137432A1 (de) 2001-10-04

Similar Documents

Publication Publication Date Title
DE69626660D1 (en) 2-alkylpyrrolidine
WO1999037340A3 (en) Biological fluid treatment system
EP0330047A3 (en) Method for the sterilization of blood, blood derivatives, plasma derivatives, cell suspensions or the like
SI1082314T1 (en) New dipeptidyl peptidase iv effectors
GR3037074T3 (en) Protein kinase c inhibitors
EP0895781A3 (de) Verwendung von Benzofuranen, Benzothiophene oder Indolen zur Herstellung eines Arzneimittels zur Behandlung von durch einen Überschuss an Tachykininen hergerufenen Störungen
PT817627E (pt) Inibidores da proteina cinase c
MY106705A (en) Composites and methods for making same.
MY109486A (en) Method employing type ii endoglycosidase
IL142220A0 (en) Method of treating viral hemorrhagic fever
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
ATE314858T1 (de) Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen
WO2021195470A3 (en) Identification and use of compounds in the treatment or prevention of severe acute respiratory syndrome coronavirus 2
HK1039449A1 (zh) 治疗多发性硬化的方法
ZA968785B (en) Snatch block pins.
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
EP1324761A4 (de) Uridin-therapie für patienten mit erhöhten purin-werten
MX9605072A (es) Dispositivo dispensador para pretratamiento.
BR9915984A (pt) Método de tratar púrpura trombocitopênica e sìndrome urêmica hemolìtica
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ES2193185T3 (es) Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados.
IL142255A0 (en) Method of treating heparin-induced thrombocytopenia
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
AU2001280093A1 (en) Method for the prevention and treatment of retinopathy
IL142247A0 (en) Method of treating sickle cell disease and thalassemia